These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37258251)

  • 1. Landscape of cancer biomarker testing in England following genomic services reconfiguration: insights from a nationwide pathologist survey.
    Taniere P; Nicholson AG; Gosney JR; Montero Fernandez MA; Bury D; Moore DA; Verghese E; Soomro I; Joseph L; Bhatt N; Viola P; Bains R; Lanctot AG; Ryan J
    J Clin Pathol; 2024 Jun; 77(7):486-494. PubMed ID: 37258251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Pathology of Lung Cancer.
    Roy-Chowdhuri S
    Surg Pathol Clin; 2021 Sep; 14(3):369-377. PubMed ID: 34373089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges in diagnosis and biomarker testing for RET-altered lung and thyroid cancer care: an international mixed-method study.
    Lazure P; Sireci A; Subbiah V; Murray S; Grohé C; Sherman SI; Kelly E; Bubach P; Péloquin S
    BMC Med Educ; 2023 Jun; 23(1):410. PubMed ID: 37277734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimising Exome Prenatal Sequencing Services (EXPRESS): a study protocol to evaluate rapid prenatal exome sequencing in the NHS Genomic Medicine Service.
    Hill M; Ellard S; Fisher J; Fulop N; Knight M; Kroese M; Ledger J; Leeson-Beevers K; McEwan A; McMullan D; Mellis R; Morris S; Parker M; Tapon D; Baple E; Blackburn L; Choudry A; Lafarge C; McInnes-Dean H; Peter M; Ramakrishnan R; Roberts L; Searle B; Smith E; Walton H; Wynn SL; Han Wu W; Chitty LS
    NIHR Open Res; 2022; 2():10. PubMed ID: 35935673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virtually the same? Examining the impact of the COVID-19 related shift to virtual lung cancer multidisciplinary team meetings in the UK National Health Service: a mixed methods study.
    Groothuizen JE; Aroyewun E; Zasada M; Harris J; Hewish M; Taylor C
    BMJ Open; 2023 Jun; 13(6):e065494. PubMed ID: 37328174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mixed-methods evaluation of the NHS Genomic Medicine Service for paediatric rare diseases: study protocol.
    Lewis C; Buchanan J; Clarke A; Clement E; Friedrich B; Hastings-Ward J; Hill M; Horn R; Lucassen AM; Patch C; Pickard A; Roberts L; Sanderson SC; Wynn SL; Vindrola-Padros C; Lakhanpaul M
    NIHR Open Res; 2021; 1():23. PubMed ID: 35098132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Programmed Death Ligand-1 Immunohistochemistry--A New Challenge for Pathologists: A Perspective From Members of the Pulmonary Pathology Society.
    Sholl LM; Aisner DL; Allen TC; Beasley MB; Borczuk AC; Cagle PT; Capelozzi V; Dacic S; Hariri L; Kerr KM; Lantuejoul S; Mino-Kenudson M; Raparia K; Rekhtman N; Roy-Chowdhuri S; Thunnissen E; Tsao MS; Yatabe Y;
    Arch Pathol Lab Med; 2016 Apr; 140(4):341-4. PubMed ID: 26780537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Best-Practice Biomarker Testing of Oesophago-Gastric Cancer in the UK: Expert Consensus Recommendations Developed Using a Modified Delphi.
    West NP; Mansoor W; Taniere P; Smyth E; Rodriguez-Justo M; Oniscu A; Carter P
    Clin Oncol (R Coll Radiol); 2024 Nov; 36(11):701-709. PubMed ID: 39183086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dermatopathologist assessment of "pathologist-to-dermatologist" communication for dermatopathology services.
    Sheikh UA; Sufficool KE; Buchanan P; Armbrecht ES; Burkemper NM; Vidal CI
    J Cutan Pathol; 2020 Apr; 47(4):328-338. PubMed ID: 31837051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The leading role of pathology in assessing the somatic molecular alterations of cancer: Position Paper of the European Society of Pathology.
    Matias-Guiu X; Stanta G; Carneiro F; Ryska A; Hoefler G; Moch H;
    Virchows Arch; 2020 Apr; 476(4):491-497. PubMed ID: 32124002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer pathology services in sub-Saharan Africa: a survey within population-based cancer registries.
    Ziegenhorn HV; Frie KG; Ekanem IO; Ebughe G; Kamate B; Traore C; Dzamalala C; Ogunbiyi O; Igbinoba F; Liu B; Bauer M; Thomssen C; Parkin DM; Wickenhauser C; Kantelhardt EJ
    BMC Health Serv Res; 2020 Oct; 20(1):912. PubMed ID: 33008380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathologists at the Leading Edge of Optimizing the Tumor Tissue Journey for Diagnostic Accuracy and Molecular Testing.
    De Las Casas LE; Hicks DG
    Am J Clin Pathol; 2021 May; 155(6):781-792. PubMed ID: 33582767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimising tissue acquisition and the molecular testing pathway for patients with non-small cell lung cancer: A UK expert consensus statement.
    Navani N; Butler R; Ibrahimo S; Verma A; Evans M; Doherty GJ; Ahmed S
    Lung Cancer; 2022 Oct; 172():142-153. PubMed ID: 36099709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Testing in Anatomic Pathology and Adherence to Guidelines: A College of American Pathologists Q-Probes Study of 2230 Testing Events Reported by 26 Institutions.
    Volmar KE; Idowu MO; Souers RJ; Nakhleh RE
    Arch Pathol Lab Med; 2015 Sep; 139(9):1115-24. PubMed ID: 26317453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Digital Solution for an Advanced Breast Tumor Board: Pilot Application Cocreation and Implementation Study.
    Hodroj K; Pellegrin D; Menard C; Bachelot T; Durand T; Toussaint P; Dufresne A; Mery B; Tredan O; Goulvent T; Heudel P
    JMIR Cancer; 2023 May; 9():e39072. PubMed ID: 37200077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survey of UK histopathology consultants' attitudes towards academic and molecular pathology.
    Brockmoeller S; Young C; Lee J; Arends MJ; Wilkins BS; Thomas GJ; Oien KA; Jones L; Hunter KD
    J Clin Pathol; 2019 Jun; 72(6):399-405. PubMed ID: 30910824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Traditional Diagnostics versus Disruptive Technology: The Role of the Pathologist in the Era of Liquid Biopsy.
    Sholl LM; Oxnard GR; Paweletz CP
    Cancer Res; 2020 Aug; 80(16):3197-3199. PubMed ID: 32606002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation of the updated NICE haematological cancers (NG47) improving outcomes guidelines across Specialist Integrated Haematological Malignancy Diagnostic Services (SIHMDS) in England: a UK NEQAS LI survey.
    Cartwright A; Snowden JA; Whitehouse H; Scott S; Whitby L
    J Clin Pathol; 2023 Sep; 76(9):618-623. PubMed ID: 35508367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of COVID-19 on the practice of breast pathologists: a survey of breast pathologists in the UK and Ireland.
    Elghobashy M; Wahab L; Gunavardhan A; O'Sullivan E; Provenzano E; Deb R; Pritchard S; Di Palma S; Ellis IO; Boyd C; Pinder SE; Shaaban AM;
    J Clin Pathol; 2023 Apr; 76(4):234-238. PubMed ID: 34620607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Educational Value of Surgical Multidisciplinary Team Meetings for Learning Non-Technical Skills - A Pilot Survey of Trainees From Two UK Deaneries.
    Trivedi DB
    J Surg Educ; 2019; 76(4):1034-1047. PubMed ID: 30792161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.